Job Description

Professor-Researcher Position: Immunology-Oncology Axis
Hôpital Maisonneuve-Rosemont Research Center and Faculty of Medicine, Université de Montréal

The Hôpital Maisonneuve-Rosemont Research Center (CR-HMR), an academic institution affiliated with the Université de Montréal, is seeking applications for a Professor-Researcher position to join the Immunology-Oncology research division. The candidate must demonstrate strong leadership, stand out internationally, and present a research program that aligns with the priorities of the CR-HMR and the Faculty of Medicine, including cell and/or gene therapy, manipulation of human immune cells, development of CAR-T/CAR-NK, B cell differentiation, malignant transformation of immune cells, development of lymphomas, leukemias or myeloma, or other related research. This person must also share the HMR research centre’s vision of excellence and demonstrate a collaborative spirit.

The CR-HMR is housed within the Hôpital Maisonneuve-Rosemont (HMR), one of the largest hospitals in Quebec serving a population of over 500,000 people. The HMR is home to a hematopoietic stem cell transplant centre, the Center of Excellence in Cellular Therapy (CETC), the Institut Universitaire d’hématologie-oncologie et de thérapie cellulaire, the Centre universitaire d’ophtalmologie of the Université de Montréal, the largest dialysis centre in Quebec, and a partner patient space within the ambulatory care centre. This clinical and research expertise, recognized nationally and internationally, is directly linked to the CR-HMR’s four main research areas: immunology-oncology, vision health, nephrology, and evaluative research and patient experience. These axes include a continuum of fundamental, translational, clinical, and evaluative research.

Within the immunology-oncology axis, the research activities of the 17 regular researchers focus on the study of cancers, including hematological cancers, and on the immune system. Oncology researchers study the molecular mechanisms controlling the development of cancers and the response to cancer treatments, while immunology researchers investigate the events governing immune responses to infections and tumors. This leads to new therapeutic targets and cellular therapies that, coupled with evaluative research and the CETC, can and have transformed patient care.

The CR-HMR is affiliated with the Université de Montréal, which, in collaboration with its affiliated schools, HEC Montréal and Polytechnique Montréal, is the main hub of higher education in Quebec. According to Times Higher Education, the Université de Montréal, with its 13 faculties and schools, is one of the top 3 research universities in Canada and ranks 125th among the best universities in the world. The Université de Montréal’s vast network comprises 11 affiliated hospitals and research institutes, including the CR-HMR. With more than 10,000 international students out of a total of more than 45,000 students, as well as its 450,000 graduates around the world, the Université de Montréal ranks 3rd among Canadian universities for its international impact according to Times Higher Education. This rich and diverse academic environment is the driving force behind its international recognition in research.

 
Roles and responsibilities
• Obtain research funds from provincial and federal funding agencies to lead an innovative and productive research program in immunology-oncology
• Supervise graduate students
• Actively participate in the academic life of the CR-HMR and the Faculty of Medicine
• Engage in and lead collaborations within the CR-HMR, the network of research centers and institutes affiliated with the University of Montreal and internationally
• Ensure national and international dissemination of their research work

Requirements
 PhD and/or MD or equivalent with research training in immunology-oncology or in a discipline
 A minimum of 3 years of additional experience
 Excellent publication record demonstrating international recognition in the field of immunology-oncology
 Have sufficient knowledge of the French language or be determined to learn it

Notes:
By obtaining the position of Professor-Researcher, the candidate agrees to submit their application to the FRQS researcher scholarship competition. With this scholarship, the candidate will apply to obtain an affiliation with the Université de Montréal as an Assistant Research Professor (Professeur.e sous octroi adjoint). For MD applicants, please note that this is a research position that is not associated with clinical privileges.

Submit your application:
The application package must include a cover letter highlighting your interest in establishing your research laboratory within the CR-HMR, your CV, and a description of your research program (3 pages). The file must be sent by email to nathalie.ross.cemtl@ssss.gouv.qc.ca and addressed to:
Sylvie Lesage, PhD
Scientific Director
Hôpital Maisonneuve-Rosemont Research Center
5415, boul. de l'Assomption Montreal (Quebec) H1T 2M4

Posting period: Ends June 1, 2025

Operations: The CR-HMR, through the Fondation de l’Hôpital Maisonneuve-Rosemont (FHMR), offers installation funds for laboratory work.

Start date: On or after January 1, 2026.